Total Price: $0.00
Contact Information
Recombinant Human CREB3L4 protein (His tag)
SKU: PDEH100312-100
To better serve you, we would like to discuss your specific requirement.
Please Contact Us for a quote.
Recombinant Human CREB3L4 protein (His tag)
| SKU # | PDEH100312 |
| Expression Host | E. coli |
Description
| Synonyms | Cyclic AMP-responsive element-binding protein 3-like protein 4;CREB3L4;cAMP-responsive element-binding protein 3-like protein 4;Androgen-induced basic leucine zipper protein (AIbZIP);Attaching to CRE-like 1 (ATCE1);Cyclic AMP-responsive element-binding pr |
| Species | Human |
| Expression_host | E.coli |
| Sequence | Glu 14-Ser 295 |
| Accession | Q8TEY5 |
| Mol_Mass | 32.2 kDa |
| AP_Mol_Mass | 40 kDa |
| Tag | N-His & C-His |
| Bio_Activity | Not validated for activity |
Properties
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Endotoxin level | Please contact us for more information. |
| Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
| Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
| Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Reconstitution | It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis |
Background
The cyclic AMP responsive element-binding protein 3-like 4 (CREB3L4) is a transcription factor highly expressed in multiple human cancers. This study aimed to investigate the regulatory effects of CREB3L4 on GC progression and angiogenesis. CREB3L4 was overexpressed in GC tissues and cell lines, and was positively correlated with advanced tumor stage and poor survival in GC patients. The upregulation of CREB3L4 in GC cells increased cell viability, promoted cell proliferation, reduced apoptosis, enhanced cell migration and invasion, and induced the formation of tubule-like endothelial structures, whereas CREB3L4 knockdown impeded tumor cell growth, attenuated cell motility, and prevented human umbilical vein endothelial cells from forming tubule-like structures. In addition, mice inoculated with CREB3L4-deficient GC cells showed significantly suppressed tumor growth compared to the group harboring wild-type tumors.